Back

Notification report


Full notification file


General information

Notification Number
B/DE/12/1750

Member State to which the notification was sent
Germany

Date of acknowledgement from the Member State Competent Authority
25/10/2012

Title of the Project
Clinical Study: Treatment of Advanced Gastrointestinal Cancer in a Phase I/II trial with modified autologous mesenchymal cells MSC_apceth_101

Proposed period of release:
01/10/2013 to 31/12/2015

Name of the Institute(s) or Company(ies)
apceth GmbH & Co.KG, ;


3. Is the same GMO release planned elsewhere in the Community?
No

Has the same GMO been notified elsewhere by the same notifier?
No

GMO characterization

GMO is a:
DNA Virus

Identity of the GMO:
genus: homo
species: sapiens
Genetically modified mesenchymal stem cells (somatic cells) derived from Homo sapiens.


Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
Mesenchymal stem cells derived from humansHomoSapiens---

European Commission administrative information

Consent given by the Member State Competent Authority:
Yes
23/05/2013 00:00:00
Remarks: